Efficacy and Immunoregulation of Pidotimod Combined with Routine Therapy in Children with Recurrent Respiratory Tract Infections / 中国药师
China Pharmacist
;
(12): 799-801, 2015.
Article
in Chinese
| WPRIM
| ID: wpr-669790
ABSTRACT
Objective:
To study the efficacy and immunoregulation of pidotimod combined with routine treatment in the children with recurrent respiratory tract infections.Methods:
Totally 114 cases of children with recurrent respiratory tract infections were divid-ed into the control group and the treatment group according to the sequence of hospitalization. The 58 patients in the control group re-ceived the conventional treatment, while the 56 patients in the treatment group were given pidotimod additionally. After two-month treatment, all the children were given 1 -6-month follow-up, and the symptom disappearance time, clinical efficacy, recurrence, physiological indices and change of immunological function in the two groups were observed and compared.Results:
The disappearance time of symptom and lung physical signs in the observation group was much shorter than that in the control group (P0. 05).Conclusion:
Pidotimod combined with routine treatment in the children with recurrent respiratory tract infections exhibits promising efficacy, which can improve immunity effectively.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
China Pharmacist
Year:
2015
Type:
Article
Similar
MEDLINE
...
LILACS
LIS